Wissam Hamou, Ph.D.

With a consistent history of shattering barriers and leaving a significant impact, Wissam embarked on his technology development journey in Next Generation Sequencing (NGS) at Mount Sinai Hospital. There, he spearheaded the creation of numerous diagnostic genetic tests on NGS platforms, marking the beginning of his impactful contributions. Transitioning seamlessly into the clinical realm, Wissam utilized the panels he developed for Genetic testing, further solidifying his commitment to positively impacting people's lives. Having now joined Syndicate Bio, Wissam continues his pursuit of effecting change and brings an unwavering focus on identifying untapped opportunities. His ingenuity and resourcefulness come to the fore as he creates innovative solutions and partnerships to overcome market challenges.